CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value
暂无分享,去创建一个
C. Brooks | A. Tefferi | A. Pardanani | W. Morice | C. Hanson | D. Zblewski | K. Reichard | R. Abdelrahman | K. L. Grogg | E. Wassie | K. K. Reichard | D. Chen | K. Reichard | Christopher Brooks | Dong Chen
[1] C. Brooks,et al. Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells , 2015, Leukemia.
[2] Yan Song,et al. Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells , 2015, Leukemia.
[3] U. Testa,et al. CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies , 2014, Biomarker Research.
[4] N. Munshi,et al. Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. , 2009, Cancer cell.
[5] N. Shinton. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .
[6] R. Larson,et al. CD4(+) CD56(+) Lineage-Negative Malignancies Are Rare Tumors of Plasmacytoid Dendritic Cells , 2005, The American journal of surgical pathology.
[7] S. Rosati,et al. Nodal and Extranodal Tumor-forming Accumulation of Plasmacytoid Monocytes/Interferon-producing Cells Associated With Myeloid Disorders , 2004, The American journal of surgical pathology.
[8] C. Peschle,et al. Interleukin-3 receptor in acute leukemia , 2004, Leukemia.
[9] R. Ketterling,et al. Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. , 2003, American journal of clinical pathology.
[10] E. Coccia,et al. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. , 2002, Blood.
[11] P. Lacor,et al. Growth factor receptor profile of CD34+ cells in AML and B‐lineage ALL and in their normal bone marrow counterparts , 2001, European journal of haematology.
[12] C. Peschle,et al. Expression of interleukin 3 and granulocyte–macrophage colony‐stimulating factor receptor common chain βc, βIT in normal haematopoiesis: lineage specificity and proliferation‐independent induction , 2000, British journal of haematology.
[13] G. Mariani,et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. , 1996, Blood.
[14] C. Bagley,et al. A Single Tyrosine Residue in the Membrane-proximal Domain of the Granulocyte-Macrophage Colony-stimulating Factor, Interleukin (IL)-3, and IL-5 Receptor Common β-Chain Is Necessary and Sufficient for High Affinity Binding and Signaling by All Three Ligands* , 1996, The Journal of Biological Chemistry.
[15] O. Majdic,et al. Failure to detect IL-3-binding sites on human mast cells. , 1990, Journal of immunology.